Pneumonia News and Research

Latest Pneumonia News and Research

Can AI find drugs to fight infection?

Streptococcus pneumoniae is a bacterial pathogen that causes life-threatening infections, including pneumonia and meningitis.

17 Sep 2026

Bacterial strains determine pneumonia and meningitis risk from air pollution

Air pollution leads to different risk of bacterial pneumonia, sepsis, and meningitis, depending on the subtype of bacteria a person has, new research suggests.

15 Sep 2026

More hospitals are adopting AI, yet the access gap is proving hard to close

A national analysis of 6,166 US hospitals found that specific workflow AI capabilities were associated with higher sepsis bundle completion rates and lower 30-day pneumonia mortality, whereas robotics showed narrower procedural associations. Geographic access remained highly uneven, with about 114.6 million people in the access-analysis population living more than 30 minutes from an AI-enabled hospital, although the observational design prevents causal conclusions.

14 Sep 2026

Autistic people face a fourteen-year deficit in life expectancy

People with autism spectrum disorder (ASD) in the United States face a 14-year deficit in life expectancy, according to a new study by researchers at Columbia University Mailman School of Public Health and University of Colorado Anschutz.

10 Sep 2026

High-dose flu vaccine protects older adults with lung disease

The risk of being hospitalized for flu or pneumonia can be reduced with a high-dose flu vaccine for older people with chronic lung disease, according to the combined results of two large clinical trials presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

8 Sep 2026

Scientists discover new mechanism for bacterial fosfomycin resistance

Bacteria can survive antibiotics in several ways, including by pumping the drugs out of their cells before they can take effect.

7 Sep 2026

Muscle matters: Simple scan could predict heart surgery risks

Around one in four heart surgery patients develop serious lung complications – but a new Adelaide-led study is testing a simple bedside scan that could predict who is most at risk before symptoms appear.

2 Sep 2026

Review highlights challenges in managing childhood enterovirus infections

Enteroviruses (EVs) are a diverse group of viruses and a common cause of multiple infections in children.

1 Sep 2026

Engineered immune cells help eliminate severe bacterial infections effectively

Severe bacterial infections remain a major global health challenge because antibiotics alone often fail when the host immune system becomes dysfunctional.

17 Aug 2026

Most Americans still believe outdated antibiotic guidance, study finds

"Always finish your antibiotics" is no longer considered medical best practice for all conditions.

13 Aug 2026

Latest hospital rankings place NYU Langone Health at the very top

NYU Langone Health continues to have the most No. 1-ranked specialties and the most top-10 ranked specialties among medical centers in the United States, according to the rankings released today by U.S. News & World Report.

4 Aug 2026

Engineered extracellular vesicles counter deadly cytokine storms in mice

The COVID-19 pandemic highlighted some severe consequences of unchecked respiratory disease, including cytokine storm.

31 Jul 2026

Oral antibiotics safely shorten hospital stays for children with pneumonia

Children hospitalized with severe pneumonia can safely switch from injectable to oral antibiotics once they begin to recover, allowing many to return home sooner and complete treatment outside hospital.

23 Jul 2026

New bacterial control strategy helps revive failing last-line antibiotics

Antimicrobial resistance is one of the world's most alarming public health challenges, because the multidrug-resistant (MDR) gram-negative bacteria increasingly render even last-line antibiotics ineffective, leading to substantially higher mortality rates.

23 Jul 2026

Study reveals bacterial strategy behind antibiotic tolerance and persistence

Antibiotics are a medical marvel, but many microbes are gaining the ability to resist and tolerate these therapeutics.

22 Jul 2026

Rising antimicrobial resistance in children threatens life-saving antibiotic effectiveness

Antimicrobial resistance in children is rising globally and will worsen over the next decade, threatening the effectiveness of life‑saving antibiotics, according to a world-first monitoring platform.

20 Jul 2026

Cell death crosstalk network drives acute respiratory distress syndrome

Acute respiratory distress syndrome (ARDS) remains one of the deadliest complications of severe infections, sepsis, trauma, and viral pneumonia, yet decades of research have produced few targeted therapies capable of improving patient outcomes.

14 Jul 2026

GLP-1 drugs may reduce lung scarring from Long COVID in diabetic patients

GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well.

9 Jul 2026

Nerve stimulation methods provide safe relief for oropharyngeal dysphagia

Dysphagia, a severe comorbidity of many neurological diseases, often lacks targeted therapies. This critical review assessed the clinical effectiveness and safety of electrical stimulation of cranial nerves for treating dysphagia, including implantable (direct nerve stimulation), minimally invasive (pharyngeal electrical stimulation, PES), and non‑invasive (transcutaneous) approaches.

30 Jun 2026

Cryo-EM microscopy uncovers structure of bacteria behind gum disease

Periodontal (gum) disease is one of the most prevalent diseases worldwide, caused by the bacterium Porphyromonas gingivalis (P. gingivalis). In Japan alone, approximately 80% of adults over 30 years old are affected or considered at risk.

30 Jun 2026